Skip to main content

Comprehensive Non-GLP Safety & Toxicology Services

Early toxicology assessments are critical for identifying potential adverse effects and guiding strategic decisions in drug development. Xyzagen provides non-GLP safety pharmacology and toxicology screening to evaluate compound tolerability, organ-specific toxicity, and functional safety—helping you de-risk programs before initiating GLP or regulatory studies.

Non-GLP Toxicology Capabilities

Our flexible and rapid non-GLP platform supports a range of studies to evaluate safety and organ-specific toxicity. Representative capabilities include:

Acute & Subacute Toxicity: Single- and repeat-dose studies in rodents
Hematology & Clinical Chemistry: Biomarker and toxicity assessments
Respiratory & CNS Safety: Behavioral and functional evaluations
Histopathology & Organ-Specific Toxicity: Liver, kidney, GI, immune toxicity

Applications Across Drug Development

These studies provide early insight into potential adverse effects, support lead optimization, and help prioritize compounds with favorable safety profiles. By identifying risks early, Xyzagen enables smarter progression to GLP toxicology, IND-enabling studies, and first-in-human trials.

Representative Non-GLP Toxicology Studies

Xyzagen’s non-GLP toxicology platform includes a broad range of studies to assess safety across organ systems and functional endpoints. Representative studies include:

Acute & Subacute Toxicity

Single-dose rodent
Repeat-dose rodent

Respiratory & CNS Safety

Respiratory rate
Motor function evaluation
Behavioral assessment

Hematology & Clinical Chemistry

Blood biomarkers
Kidney function
Liver function

Applications & Custom Models

Rapid toxicity screens
Custom organ-specific assays
Lead optimization

Why Choose Xyzagen for Early Toxicology?

Xyzagen combines toxicology expertise with pharmacology, PK/PD modeling, and flexible study design. Our team delivers high-quality, actionable data with rapid turnaround—helping clients make informed decisions, reduce late-stage attrition, and accelerate program timelines.

Contact Us

Explore early toxicology solutions for your program. Contact Xyzagen to discuss a tailored study plan.

Schedule a Consultation

Safety & NonGLP Toxicology

Early toxicology assessments are critical for de-risking drug development. Xyzagen offers non-GLP safety pharmacology and toxicology screening to identify potential adverse effects before regulatory studies.

Non-GLP Toxicology Services

Acute & Subacute Toxicity Studies – Single and repeat-dose toxicology in rodents
Hematology & Clinical Chemistry – Biomarker & toxicity assessments
Cardiovascular Toxicity – QT prolongation, hemodynamic monitoring
Respiratory & CNS Safety Assessments – Behavioral & functional evaluations
Histopathology & Organ-Specific Toxicity – Liver, kidney, GI, immune toxicity

We support early decision-making with rapid turnaround toxicity screens before advancing to GLP studies.

Get in touch to explore early toxicology solutions for your program!